# NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease

> **NCT05344404** · NA · COMPLETED · sponsor: **Haukeland University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Nicotinamide Riboside
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT05344404
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-29
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05344404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05344404, "NR-SAFE: Safety of High-dose Nicotinamide Riboside (NR) in Parkinson's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05344404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*